Recent EBS News
- Emergent BioSolutions Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/01/2024 08:57:22 PM
- Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position • GlobeNewswire Inc. • 05/01/2024 08:10:00 PM
- Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone • GlobeNewswire Inc. • 05/01/2024 03:03:28 PM
- Emergent BioSolutions Announces Amendment to its Existing Credit Facility • GlobeNewswire Inc. • 04/30/2024 09:26:55 PM
- Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/22/2024 12:05:00 PM
- Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis • GlobeNewswire Inc. • 03/28/2024 12:15:03 PM
- Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility • GlobeNewswire Inc. • 03/25/2024 12:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/08/2024 09:21:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 01:31:51 AM
- Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results • GlobeNewswire Inc. • 03/06/2024 09:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:15:47 PM
- U.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices Climb • IH Market News • 03/06/2024 11:02:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:43:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:42:33 PM
- Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024 • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 01:30:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 01:28:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:25:51 PM
- Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO • GlobeNewswire Inc. • 02/21/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 12:41:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 01:40:06 PM
- Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024 • GlobeNewswire Inc. • 01/09/2024 12:30:00 PM
- Wall Street Highlights: Apple Appeals Watch Ban, Tesla to Launch Updated Model Y, and More • IH Market News • 12/27/2023 11:08:22 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM